InterMedical Care and Lab Hospital PCL (BKK:IMH) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:IMH InterMedical Care and Lab Hospital PCL BKK:IMH
62 GF Score
Price ฿3.00
GF Value ฿4.44
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is InterMedical Care and Lab Hospital PCL Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of InterMedical Care and Lab Hospital PCL is: High Risk: High uncertainty.


InterMedical Care and Lab Hospital PCL  (BKK:IMH) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


InterMedical Care and Lab Hospital PCL Risk Assessment Related Terms


BKK:IMH vs HCA, THC, DVA: Risk Assessment Comparison

For the Medical Care Facilities subindustry, InterMedical Care and Lab Hospital PCL's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InterMedical Care and Lab Hospital PCL Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InterMedical Care and Lab Hospital PCL's Risk Assessment distribution charts can be found below:

* The bar in red indicates where InterMedical Care and Lab Hospital PCL's Risk Assessment falls into.


BKK:IMH
62GF Score
InterMedical Care and Lab Hospital PCL BKK:IMH
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is InterMedical Care and Lab Hospital PCL (BKK:IMH) Overvalued in 2026?

Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued. The current stock price of ฿3.00 is trading 32.4% below its estimated GF Value™ of ฿4.44. GuruFocus considers InterMedical Care and Lab Hospital PCL to be Possible Value Trap.

Key valuation signals for BKK:IMH:

  • Risk Assessment:
  • GF Value™: ฿4.44 vs. price of ฿3.00 (32.4% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the BKK:IMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InterMedical Care and Lab Hospital PCL Business Description

Address 442 Bang Waek Road, Bang Waek Sub-district, Pha-si-cha-roen District, Bangkok, THA, 10160
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
62GF Score

Get the complete analysis for BKK:IMH

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿3.00
Price
฿4.44
GF Value